Form D · Biotechnology

Paralos Bioscience Inc.

Los Angeles, CA · CIK 0002080259

Offering snapshot reported Jun 23, 2026 · SEC filing

Reported sold
$647K
Offering amount: $1M
Investors reported
5
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Jul 28, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$323K$647KAug 7, 2025: $50,000.00Aug 7, 2025Sep 24, 2025: $150,000.00Apr 17, 2026: $328,900.00Apr 17, 2026Jun 23, 2026: $646,900.00Jun 23, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$328,900 → $646,900
  • Reported investors3 → 5

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 23, 2026Amendment$646,900$318,000vs Apr 17, 20265SEC filing
Apr 17, 2026Amendment$328,900$178,900vs Sep 24, 20253SEC filing
Sep 24, 2025Amendment$150,000$100,000vs Aug 7, 20252SEC filing
Aug 7, 2025Initial$50,000No comparison1SEC filing

Offering details

Securities
Equity, Debt
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-554029

Source: Form D, filed Jun 23, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Irene Chen Director, Executive
Yanxi Yang Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
570 Westwood Plaza Lab Room 6350 Attn: Paralos Bioscience Inc (Magnify)
Los Angeles, CA, 90095